99 related articles for article (PubMed ID: 21683777)
1. Improvement of the wettability and dissolution of fenofibrate compacts by plasma treatment.
Buch P; Meyer C; Langguth P
Int J Pharm; 2011 Sep; 416(1):49-54. PubMed ID: 21683777
[TBL] [Abstract][Full Text] [Related]
2. Effects of oxygen plasma treatment on the surface wettability and dissolution of furosemide compacts.
Naseem A; Olliff CJ; Martini LG; Lloyd AW
J Pharm Pharmacol; 2003 Nov; 55(11):1473-8. PubMed ID: 14713357
[TBL] [Abstract][Full Text] [Related]
3. Preparation of fenofibrate immediate-release tablets involving wet grinding for improved bioavailability.
Zhang L; Chai G; Zeng X; He H; Xu H; Tang X
Drug Dev Ind Pharm; 2010 Sep; 36(9):1054-63. PubMed ID: 20818965
[TBL] [Abstract][Full Text] [Related]
4. Effects of plasma irradiation on the wettability and dissolution of compacts of griseofulvin.
Naseem A; Olliff CJ; Martini LG; Lloyd AW
Int J Pharm; 2004 Jan; 269(2):443-50. PubMed ID: 14706255
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of griseofulvin release from liquisolid compacts.
Hentzschel CM; Alnaief M; Smirnova I; Sakmann A; Leopold CS
Eur J Pharm Biopharm; 2012 Jan; 80(1):130-5. PubMed ID: 21846502
[TBL] [Abstract][Full Text] [Related]
6. Improved dissolution rate and bioavailability of fenofibrate pellets prepared by wet-milled-drug layering.
Wang P; Luo Q; Miao Y; Ying L; He H; Cai C; Tang X
Drug Dev Ind Pharm; 2012 Nov; 38(11):1344-53. PubMed ID: 22283480
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of dissolution rate of piroxicam using liquisolid compacts.
Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M; Nokhodchi A
Farmaco; 2005 Apr; 60(4):361-5. PubMed ID: 15848213
[TBL] [Abstract][Full Text] [Related]
8. Suitability of various excipients as carrier and coating materials for liquisolid compacts.
Hentzschel CM; Sakmann A; Leopold CS
Drug Dev Ind Pharm; 2011 Oct; 37(10):1200-7. PubMed ID: 21449826
[TBL] [Abstract][Full Text] [Related]
9. A One-Step Twin-Screw Melt Granulation with Gelucire 48/16 and Surface Adsorbent to Improve the Solubility of Poorly Soluble Drugs: Effect of Formulation Variables on Dissolution and Stability.
Sarabu S; Kallakunta VR; Butreddy A; Janga KY; Ajjarapu S; Bandari S; Zhang F; Murthy SN; Repka MA
AAPS PharmSciTech; 2021 Feb; 22(3):79. PubMed ID: 33606113
[TBL] [Abstract][Full Text] [Related]
10. Improvement of dissolution properties of Carbamazepine through application of the liquisolid tablet technique.
Tayel SA; Soliman II; Louis D
Eur J Pharm Biopharm; 2008 May; 69(1):342-7. PubMed ID: 17949959
[TBL] [Abstract][Full Text] [Related]
11. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.
Nokhodchi A; Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M
J Pharm Pharm Sci; 2005 Jan; 8(1):18-25. PubMed ID: 15946594
[TBL] [Abstract][Full Text] [Related]
12. Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants.
Srinarong P; Faber JH; Visser MR; Hinrichs WL; Frijlink HW
Eur J Pharm Biopharm; 2009 Sep; 73(1):154-61. PubMed ID: 19465121
[TBL] [Abstract][Full Text] [Related]
13. Hydrodynamic simulation (computational fluid dynamics) of asymmetrically positioned tablets in the paddle dissolution apparatus: impact on dissolution rate and variability.
D'Arcy DM; Corrigan OI; Healy AM
J Pharm Pharmacol; 2005 Oct; 57(10):1243-50. PubMed ID: 16259752
[TBL] [Abstract][Full Text] [Related]
14. Advantages of celecoxib nanosuspension formulation and transformation into tablets.
Dolenc A; Kristl J; Baumgartner S; Planinsek O
Int J Pharm; 2009 Jul; 376(1-2):204-12. PubMed ID: 19426794
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
16. The influence of supercritical carbon dioxide (SC-CO2) processing conditions on drug loading and physicochemical properties.
Ahern RJ; Crean AM; Ryan KB
Int J Pharm; 2012 Dec; 439(1-2):92-9. PubMed ID: 23041132
[TBL] [Abstract][Full Text] [Related]
17. Investigating the effect of moisture protection on solid-state stability and dissolution of fenofibrate and ketoconazole solid dispersions using PXRD, HSDSC and Raman microscopy.
Kanaujia P; Lau G; Ng WK; Widjaja E; Schreyer M; Hanefeld A; Fischbach M; Saal C; Maio M; Tan RB
Drug Dev Ind Pharm; 2011 Sep; 37(9):1026-35. PubMed ID: 21417604
[TBL] [Abstract][Full Text] [Related]
18. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
Hu J; Ng WK; Dong Y; Shen S; Tan RB
Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643
[TBL] [Abstract][Full Text] [Related]
19. Developing Quantitative In Vitro-In Vivo Correlation for Fenofibrate Immediate-Release Formulations With the Biphasic Dissolution-Partition Test Method.
Xu H; Shi Y; Vela S; Marroum P; Gao P
J Pharm Sci; 2018 Jan; 107(1):476-487. PubMed ID: 28666964
[TBL] [Abstract][Full Text] [Related]
20. Effect of surface charge and hydrophobicity of polyurethanes and silicone rubbers on L929 cells response.
Khorasani MT; Moemenbellah S; Mirzadeh H; Sadatnia B
Colloids Surf B Biointerfaces; 2006 Aug; 51(2):112-9. PubMed ID: 16872811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
